Morgan Stanley’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-809,248
| Closed | -$27.9M | – | 7278 |
|
|
2020
Q3 | $27.9M | Buy |
809,248
+453,795
| +128% | +$15.6M | 0.01% | 1240 |
|
|
2020
Q2 | $5.94M | Sell |
355,453
-663,239
| -65% | -$11.1M | ﹤0.01% | 2491 |
|
|
2020
Q1 | $14.7M | Buy |
1,018,692
+466,231
| +84% | +$6.72M | ﹤0.01% | 1497 |
|
|
2019
Q4 | $18.5M | Buy |
552,461
+66,565
| +14% | +$2.23M | ﹤0.01% | 1732 |
|
|
2019
Q3 | $10.2M | Sell |
485,896
-259,294
| -35% | -$5.43M | ﹤0.01% | 2105 |
|
|
2019
Q2 | $15.5M | Sell |
745,190
-3,097
| -0.4% | -$64.5K | ﹤0.01% | 1718 |
|
|
2019
Q1 | $16.7M | Sell |
748,287
-184,024
| -20% | -$4.11M | ﹤0.01% | 1582 |
|
|
2018
Q4 | $22.3M | Sell |
932,311
-12,977
| -1% | -$310K | 0.01% | 1375 |
|
|
2018
Q3 | $25.8M | Sell |
945,288
-13,516
| -1% | -$369K | 0.01% | 1455 |
|
|
2018
Q2 | $25.8M | Buy |
958,804
+242,895
| +34% | +$6.53M | 0.01% | 1414 |
|
|
2018
Q1 | $22.8M | Buy |
715,909
+68,008
| +10% | +$2.16M | 0.01% | 1551 |
|
|
2017
Q4 | $24.5M | Buy |
647,901
+3,615
| +0.6% | +$137K | 0.01% | 1494 |
|
|
2017
Q3 | $16M | Buy |
644,286
+65,832
| +11% | +$1.63M | ﹤0.01% | 1790 |
|
|
2017
Q2 | $11.9M | Buy |
578,454
+122,143
| +27% | +$2.51M | ﹤0.01% | 2011 |
|
|
2017
Q1 | $9.92M | Buy |
456,311
+127,700
| +39% | +$2.78M | ﹤0.01% | 2204 |
|
|
2016
Q4 | $6.72M | Buy |
328,611
+92,181
| +39% | +$1.89M | ﹤0.01% | 2682 |
|
|
2016
Q3 | $3.55M | Buy |
236,430
+36,461
| +18% | +$547K | ﹤0.01% | 3002 |
|
|
2016
Q2 | $2.16M | Buy |
199,969
+177,330
| +783% | +$1.92M | ﹤0.01% | 3359 |
|
|
2016
Q1 | $307K | Buy |
22,639
+17,812
| +369% | +$242K | ﹤0.01% | 4720 |
|
|
2015
Q4 | $89K | Buy |
4,827
+4,527
| +1,509% | +$83.5K | ﹤0.01% | 5471 |
|
|
2015
Q3 | $8K | Buy |
+300
| New | +$8K | ﹤0.01% | 6307 |
|